Looking to work with companies seeking guidance to develop personalised therapies?
Cancer immunotherapy drug developers are actively seeking external partners to provide solutions to the challenges they face as advance neoantigen targeting immunotherapies to the clinic.
The 6th Annual Neoantigen Summit Europe offers a unique opportunity to:
Collaborate with key industry decision-makers in the space
Capitalise on the market share early
Cement your position as an industry leader
Support the industry growth of neoantigen identification, clinical trial successes, etc
Provide the best adjuvants to elicit a strong, profound immune response among a host of other services
We’ll work with you to build a bespoke partnership package focused on making valuable connections and generating actionable leads to ensure you meet your commercial objectives.
What 2022's Partners Had To Say:
“The quality of the speakers was outstanding, and the industry partners present had a big diversity.”
Seqalis
“Good opportunity to relate to known contacts, but as well meet new potential clients. Good support with organizing 1-2-1 meetings.”
Personalis Inc
"Passion for innovation - The event was well organised and informative”
NEC Oncolmmunity
“Nice networking and learning opportunity, eager to see more clinical phase / downstream projects in the future as they move forward. Good to be back out meeting people in person.”
Almac
Past Attendees:
